Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression
✍ Scribed by Aisha Nasef; Christelle Mazurier; Sandrine Bouchet; Sabine François; Alain Chapel; Dominique Thierry; Norbert-Claude Gorin; Loïc Fouillard
- Book ID
- 113527126
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 477 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0008-8749
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Noggin is a secreted protein that inhibits the binding of bone morphogenetic proteins (BMPs) to their cognate receptor. Its role in human mesenchymal stem cell differentiation has not been well studied. Here, we studied the effect of noggin on human mesenchymal stem cell differentiation
## Abstract For developing gene therapy for chronic myelogenous leukemia (CML), we evaluated the feasibility of using autologous bone marrow stromal cells (BMSCs) of one CML patient as a target cell population and studied the efficiency of recombinant adenovirus‐mediated human Gamma Interferon (hIF